25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Oxurion NV
Buy, Hold or Sell?

Let's analyze Oxurion together

I guess you are interested in Oxurion NV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Oxurion NV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Oxurion NV

I send you an email if I find something interesting about Oxurion NV.

Quick analysis of Oxurion (30 sec.)










What can you expect buying and holding a share of Oxurion? (30 sec.)

How much money do you get?

How much money do you get?
‚ā¨0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
‚ā¨0.00
Expected worth in 1 year
‚ā¨0.00
How sure are you?
10.0%

+ What do you gain per year?

Total Gains per Share
‚ā¨0.00
Return On Investment
-2,803.3%

For what price can you sell your share?

Current Price per Share
‚ā¨0.00
Expected price per share
‚ā¨0.0001 - ‚ā¨0.0002
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Oxurion (5 min.)




Live pricePrice per Share (EOD)

‚ā¨0.00

Intrinsic Value Per Share

‚ā¨-0.02 - ‚ā¨0.01

Total Value Per Share

‚ā¨-0.02 - ‚ā¨0.01

2. Growth of Oxurion (5 min.)




Is Oxurion growing?

Current yearPrevious yearGrowGrow %
How rich?-$14.2m-$4.9m-$9.3m-65.2%

How much money is Oxurion making?

Current yearPrevious yearGrowGrow %
Making money-$20.5m-$34.3m$13.7m67.0%
Net Profit Margin-7,212.5%-5,325.2%--

How much money comes from the company's main activities?

3. Financial Health of Oxurion (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#926 / 982

Most Revenue
#620 / 982

Most Profit
#718 / 982

Most Efficient
#888 / 982
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Oxurion? (5 min.)

Welcome investor! Oxurion's management wants to use your money to grow the business. In return you get a share of Oxurion.

What can you expect buying and holding a share of Oxurion?

First you should know what it really means to hold a share of Oxurion. And how you can make/lose money.

Speculation

The Price per Share of Oxurion is ‚ā¨0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Oxurion.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Oxurion, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ‚ā¨0.00. Based on the TTM, the Book Value Change Per Share is ‚ā¨0.00 per quarter. Based on the YOY, the Book Value Change Per Share is ‚ā¨0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ‚ā¨0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Oxurion.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share
Usd Eps0.00-1,675.7%0.00-1,675.7%0.00-2,799.0%0.00-2,820.6%0.00-2,867.9%
Usd Book Value Change Per Share0.00-760.0%0.00-760.0%0.00-307.0%0.00-2,093.5%0.00-2,402.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-760.0%0.00-760.0%0.00-307.0%0.00-2,093.5%0.00-2,402.4%
Usd Price Per Share0.00-0.00-0.02-1.59-2.92-
Price to Earnings Ratio-0.58--0.58--7.36--518.18--515.88-
Price-to-Total Gains Ratio-1.28--1.28--67.12--545.40--578.83-
Price to Book Ratio-0.84--0.84--50.89--3,647.99--1,658.17-
Price-to-Total Gains Ratio-1.28--1.28--67.12--545.40--578.83-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.00010844
Number of shares9221689
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (9221689 shares)-7,008.15-19,305.78
Gains per Year (9221689 shares)-28,032.62-77,223.13
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-28033-280430-77223-77233
20-56065-560760-154446-154456
30-84098-841090-231669-231679
40-112130-1121420-308893-308902
50-140163-1401750-386116-386125
60-168196-1682080-463339-463348
70-196228-1962410-540562-540571
80-224261-2242740-617785-617794
90-252294-2523070-695008-695017
100-280326-2803400-772231-772240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%4.014.00.022.2%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%8.010.00.044.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.018.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%8.010.00.044.4%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Oxurion

About Oxurion NV

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness. It focuses on developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

Fundamental data was last updated by Penke on 2024-07-07 23:52:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Oxurion NV.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit¬†Oxurion earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare¬†Oxurion to the¬†Biotechnology industry mean.
  • A Net Profit Margin of -7,212.5%¬†means that¬†€-72.13 for each €1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oxurion NV:

  • The MRQ is -7,212.5%. The company is making a huge loss. -2
  • The TTM is -7,212.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-7,212.5%TTM-7,212.5%0.0%
TTM-7,212.5%YOY-5,325.2%-1,887.3%
TTM-7,212.5%5Y-3,556.8%-3,655.7%
5Y-3,556.8%10Y-1,967.3%-1,589.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7,212.5%-168.6%-7,043.9%
TTM-7,212.5%-209.9%-7,002.6%
YOY-5,325.2%-235.1%-5,090.1%
5Y-3,556.8%-390.8%-3,166.0%
10Y-1,967.3%-505.1%-1,462.2%
1.1.2. Return on Assets

Shows how efficient Oxurion is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Oxurion to the¬†Biotechnology industry mean.
  • -289.6% Return on Assets means that¬†Oxurion generated¬†€-2.90 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oxurion NV:

  • The MRQ is -289.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -289.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-289.6%TTM-289.6%0.0%
TTM-289.6%YOY-264.2%-25.4%
TTM-289.6%5Y-173.9%-115.7%
5Y-173.9%10Y-98.2%-75.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-289.6%-11.7%-277.9%
TTM-289.6%-11.8%-277.8%
YOY-264.2%-11.2%-253.0%
5Y-173.9%-13.2%-160.7%
10Y-98.2%-14.6%-83.6%
1.1.3. Return on Equity

Shows how efficient Oxurion is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Oxurion to the¬†Biotechnology industry mean.
  • 0.0% Return on Equity means Oxurion generated €0.00¬†for each¬†€1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oxurion NV:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-41.7%+41.7%
5Y-41.7%10Y-33.0%-8.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.0%+14.0%
TTM--15.2%+15.2%
YOY--14.0%+14.0%
5Y-41.7%-18.8%-22.9%
10Y-33.0%-19.3%-13.7%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Oxurion NV.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Oxurion is operating .

  • Measures how much profit Oxurion makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Oxurion to the¬†Biotechnology industry mean.
  • An Operating Margin of -5,277.2%¬†means the company generated €-52.77 ¬†for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oxurion NV:

  • The MRQ is -5,277.2%. The company is operating very inefficient. -2
  • The TTM is -5,277.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-5,277.2%TTM-5,277.2%0.0%
TTM-5,277.2%YOY-3,828.4%-1,448.8%
TTM-5,277.2%5Y-2,808.3%-2,468.9%
5Y-2,808.3%10Y-1,649.9%-1,158.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,277.2%-351.1%-4,926.1%
TTM-5,277.2%-224.3%-5,052.9%
YOY-3,828.4%-243.1%-3,585.3%
5Y-2,808.3%-396.3%-2,412.0%
10Y-1,649.9%-510.1%-1,139.8%
1.2.2. Operating Ratio

Measures how efficient Oxurion is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Biotechnology industry mean).
  • An Operation Ratio of 46.56 means that the operating costs are €46.56 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Oxurion NV:

  • The MRQ is 46.559. The company is inefficient in keeping operating costs low. -1
  • The TTM is 46.559. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ46.559TTM46.5590.000
TTM46.559YOY39.284+7.275
TTM46.5595Y27.640+18.919
5Y27.64010Y16.901+10.740
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ46.5593.004+43.555
TTM46.5593.255+43.304
YOY39.2843.484+35.800
5Y27.6405.004+22.636
10Y16.9016.533+10.368
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Oxurion NV.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Oxurion is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Biotechnology industry mean).
  • A Current Ratio of 0.14¬†means the company has €0.14 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Oxurion NV:

  • The MRQ is 0.140. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.140. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.140TTM0.1400.000
TTM0.140YOY0.575-0.436
TTM0.1405Y2.190-2.050
5Y2.19010Y6.033-3.844
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1403.793-3.653
TTM0.1404.052-3.912
YOY0.5754.945-4.370
5Y2.1905.990-3.800
10Y6.0336.326-0.293
1.3.2. Quick Ratio

Measures if Oxurion is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Oxurion to the¬†Biotechnology industry mean.
  • A Quick Ratio of 0.13¬†means the company can pay off €0.13 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oxurion NV:

  • The MRQ is 0.133. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.133. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.133TTM0.1330.000
TTM0.133YOY0.365-0.233
TTM0.1335Y2.258-2.125
5Y2.25810Y6.506-4.248
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1333.186-3.053
TTM0.1333.581-3.448
YOY0.3654.803-4.438
5Y2.2585.922-3.664
10Y6.5066.430+0.076
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Oxurion NV.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Oxurion assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Oxurion to Biotechnology industry mean.
  • A Debt to Asset Ratio of 3.01¬†means that Oxurion assets are¬†financed with 301.3% credit (debt) and the remaining percentage (100% - 301.3%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of Oxurion NV:

  • The MRQ is 3.013. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 3.013. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ3.013TTM3.0130.000
TTM3.013YOY1.382+1.631
TTM3.0135Y1.181+1.832
5Y1.18110Y0.630+0.550
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0130.330+2.683
TTM3.0130.340+2.673
YOY1.3820.287+1.095
5Y1.1810.368+0.813
10Y0.6300.383+0.247
1.4.2. Debt to Equity Ratio

Measures if Oxurion is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Oxurion to the¬†Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oxurion NV:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.117-0.117
5Y0.11710Y0.103+0.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.366-0.366
TTM-0.415-0.415
YOY-0.369-0.369
5Y0.1170.441-0.324
10Y0.1030.483-0.380
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Oxurion NV

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures¬†how much money you pay¬†for each share for¬†every €1 in earnings Oxurion generates.

  • Above 15 is considered overpriced but¬†always compare¬†Oxurion to the¬†Biotechnology industry mean.
  • A PE ratio of -0.58 means the investor is paying €-0.58¬†for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oxurion NV:

  • The EOD is -0.065. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.582. Based on the earnings, the company is expensive. -2
  • The TTM is -0.582. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.065MRQ-0.582+0.518
MRQ-0.582TTM-0.5820.000
TTM-0.582YOY-7.361+6.779
TTM-0.5825Y-518.181+517.598
5Y-518.18110Y-515.883-2.298
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.065-2.610+2.545
MRQ-0.582-3.020+2.438
TTM-0.582-2.891+2.309
YOY-7.361-3.549-3.812
5Y-518.181-6.222-511.959
10Y-515.883-6.322-509.561
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Oxurion NV:

  • The EOD is -0.126. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.131. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.131. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.126MRQ-1.131+1.006
MRQ-1.131TTM-1.1310.000
TTM-1.131YOY-11.618+10.487
TTM-1.1315Y-628.921+627.790
5Y-628.92110Y-770.557+141.636
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.126-3.139+3.013
MRQ-1.131-3.748+2.617
TTM-1.131-3.717+2.586
YOY-11.618-5.038-6.580
5Y-628.921-7.998-620.923
10Y-770.557-8.522-762.035
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Oxurion is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Biotechnology industry mean).
  • A PB ratio of -0.84 means the investor is paying €-0.84¬†for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Oxurion NV:

  • The EOD is -0.093. Based on the equity, the company is expensive. -2
  • The MRQ is -0.838. Based on the equity, the company is expensive. -2
  • The TTM is -0.838. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.093MRQ-0.838+0.745
MRQ-0.838TTM-0.8380.000
TTM-0.838YOY-50.892+50.054
TTM-0.8385Y-3,647.990+3,647.152
5Y-3,647.99010Y-1,658.167-1,989.823
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0931.928-2.021
MRQ-0.8382.247-3.085
TTM-0.8382.301-3.139
YOY-50.8922.387-53.279
5Y-3,647.9903.674-3,651.664
10Y-1,658.1674.139-1,662.306
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Oxurion NV compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.0010%0.000-60%-0.002+175%-0.002+216%
Book Value Per Share---0.001-0.0010%0.000-65%0.001-211%0.006-117%
Current Ratio--0.1400.1400%0.575-76%2.190-94%6.033-98%
Debt To Asset Ratio--3.0133.0130%1.382+118%1.181+155%0.630+378%
Debt To Equity Ratio----0%-0%0.117-100%0.103-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.002-0.0020%-0.003+67%-0.003+68%-0.003+71%
Free Cash Flow Per Share---0.001-0.0010%-0.002+106%-0.002+136%-0.002+122%
Free Cash Flow To Equity Per Share--0.0000.0000%-0.001+231%-0.001+763%-0.001+802%
Gross Profit Margin--1.0071.0070%1.028-2%1.066-5%1.143-12%
Intrinsic Value_10Y_max--0.008--------
Intrinsic Value_10Y_min---0.024--------
Intrinsic Value_1Y_max---0.001--------
Intrinsic Value_1Y_min---0.002--------
Intrinsic Value_3Y_max---0.002--------
Intrinsic Value_3Y_min---0.006--------
Intrinsic Value_5Y_max---0.001--------
Intrinsic Value_5Y_min---0.011--------
Market Cap1227569.971-800%11048129.74111048129.7410%233238294.528-95%18022936803.164-100%33103756656.353-100%
Net Profit Margin---72.125-72.1250%-53.252-26%-35.568-51%-19.673-73%
Operating Margin---52.772-52.7720%-38.284-27%-28.083-47%-16.499-69%
Operating Ratio--46.55946.5590%39.284+19%27.640+68%16.901+175%
Pb Ratio-0.093+89%-0.838-0.8380%-50.892+5974%-3647.990+435289%-1658.167+197803%
Pe Ratio-0.065+89%-0.582-0.5820%-7.361+1164%-518.181+88869%-515.883+88474%
Price Per Share0.000-800%0.0010.0010%0.019-95%1.468-100%2.697-100%
Price To Free Cash Flow Ratio-0.126+89%-1.131-1.1310%-11.618+927%-628.921+55494%-770.557+68013%
Price To Total Gains Ratio-0.143+89%-1.284-1.2840%-67.119+5126%-545.397+42369%-578.834+44973%
Quick Ratio--0.1330.1330%0.365-64%2.258-94%6.506-98%
Return On Assets---2.896-2.8960%-2.642-9%-1.739-40%-0.982-66%
Return On Equity----0%-0%-0.4170%-0.3300%
Total Gains Per Share---0.001-0.0010%0.000-60%-0.002+175%-0.002+216%
Usd Book Value---14298898.400-14298898.4000%-4969805.200-65%12899371.760-211%85237093.200-117%
Usd Book Value Change Per Share---0.001-0.0010%0.000-60%-0.002+175%-0.002+216%
Usd Book Value Per Share---0.001-0.0010%0.000-65%0.001-211%0.007-117%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.002-0.0020%-0.003+67%-0.003+68%-0.003+71%
Usd Free Cash Flow---10590250.400-10590250.4000%-21769330.000+106%-25044651.760+136%-23522479.480+122%
Usd Free Cash Flow Per Share---0.001-0.0010%-0.002+106%-0.002+136%-0.002+122%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%-0.001+231%-0.001+763%-0.002+802%
Usd Market Cap1331176.877-800%11980591.89111980591.8910%252923606.586-95%19544072669.351-100%35897713718.150-100%
Usd Price Per Share0.000-800%0.0010.0010%0.021-95%1.592-100%2.924-100%
Usd Profit---20569983.600-20569983.6000%-34359214.000+67%-34625108.880+68%-35205046.000+71%
Usd Revenue--285197.200285197.2000%645218.000-56%1737208.583-84%5554079.812-95%
Usd Total Gains Per Share---0.001-0.0010%0.000-60%-0.002+175%-0.002+216%
 EOD+2 -6MRQTTM+0 -0YOY+10 -225Y+15 -1810Y+15 -18

3.2. Fundamental Score

Let's check the fundamental score of Oxurion NV based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.065
Price to Book Ratio (EOD)Between0-1-0.093
Net Profit Margin (MRQ)Greater than0-72.125
Operating Margin (MRQ)Greater than0-52.772
Quick Ratio (MRQ)Greater than10.133
Current Ratio (MRQ)Greater than10.140
Debt to Asset Ratio (MRQ)Less than13.013
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.896
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Oxurion NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.081
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Net Invested Capital  53,160-27,98025,180-14,42410,756-8,2952,461-3,641-1,180



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets6,550
Total Liabilities19,736
Total Stockholder Equity-13,186
 As reported
Total Liabilities 19,736
Total Stockholder Equity+ -13,186
Total Assets = 6,550

Assets

Total Assets6,550
Total Current Assets2,740
Long-term Assets3,810
Total Current Assets
Cash And Cash Equivalents 1,624
Short-term Investments 50
Net Receivables 878
Inventory 128
Other Current Assets 60
Total Current Assets  (as reported)2,740
Total Current Assets  (calculated)2,740
+/-0
Long-term Assets
Property Plant Equipment 245
Long-term Assets Other 3,565
Long-term Assets  (as reported)3,810
Long-term Assets  (calculated)3,810
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities19,607
Long-term Liabilities129
Total Stockholder Equity-13,186
Total Current Liabilities
Short-term Debt 12,217
Short Long Term Debt 12,006
Accounts payable 4,940
Other Current Liabilities 1,748
Total Current Liabilities  (as reported)19,607
Total Current Liabilities  (calculated)30,911
+/- 11,304
Long-term Liabilities
Long-term Liabilities  (as reported)129
Long-term Liabilities  (calculated)0
+/- 129
Total Stockholder Equity
Common Stock72,993
Retained Earnings -92,373
Accumulated Other Comprehensive Income 5,944
Other Stockholders Equity 250
Total Stockholder Equity (as reported)-13,186
Total Stockholder Equity (calculated)-13,186
+/-0
Other
Capital Stock72,993
Cash and Short Term Investments 1,674
Common Stock Shares Outstanding 1,652,094
Current Deferred Revenue702
Liabilities and Stockholders Equity 6,550
Net Debt 10,710
Net Invested Capital -1,180
Net Working Capital -16,867
Property Plant and Equipment Gross 11,264
Short Long Term Debt Total 12,334



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
> Total Assets 
37,334
51,997
67,203
101,219
142,937
129,089
239,171
271,154
220,714
178,946
121,636
150,437
114,864
65,030
34,284
18,876
11,993
6,550
6,55011,99318,87634,28465,030114,864150,437121,636178,946220,714271,154239,171129,089142,937101,21967,20351,99737,334
   > Total Current Assets 
34,218
48,354
61,448
80,108
113,477
87,784
159,751
191,634
149,168
116,693
91,439
124,283
91,089
57,015
27,054
13,409
7,106
2,740
2,7407,10613,40927,05457,01591,089124,28391,439116,693149,168191,634159,75187,784113,47780,10861,44848,35434,218
       Cash And Cash Equivalents 
32,043
40,111
30,356
75,929
85,866
57,548
139,398
164,570
123,223
93,341
58,251
56,175
64,652
42,492
24,511
9,740
3,496
1,624
1,6243,4969,74024,51142,49264,65256,17558,25193,341123,223164,570139,39857,54885,86675,92930,35640,11132,043
       Short-term Investments 
718
6,710
28,565
742
23,289
22,831
8,833
7,791
3,853
8,044
21,817
49,555
20,475
10,444
288
247
95
50
509524728810,44420,47549,55521,8178,0443,8537,7918,83322,83123,28974228,5656,710718
       Net Receivables 
0
0
0
0
0
0
0
9,874
11,506
6,274
5,181
2,626
2,012
2,293
1,410
974
825
878
8788259741,4102,2932,0122,6265,1816,27411,5069,8740000000
       Other Current Assets 
1,457
1,533
2,527
3,437
4,322
7,405
11,520
3,288
3,362
2,536
3,576
13,723
2,914
1,766
760
2,388
2,685
60
602,6852,3887601,7662,91413,7233,5762,5363,3623,28811,5207,4054,3223,4372,5271,5331,457
   > Long-term Assets 
3,116
3,643
5,755
21,111
29,460
41,305
79,420
79,520
67,885
60,373
27,645
24,594
21,064
8,015
7,230
5,467
4,887
3,810
3,8104,8875,4677,2308,01521,06424,59427,64560,37367,88579,52079,42041,30529,46021,1115,7553,6433,116
       Property Plant Equipment 
530
1,057
1,004
1,042
894
1,492
2,699
3,634
2,911
2,088
1,743
991
614
2,552
1,299
372
1,062
245
2451,0623721,2992,5526149911,7432,0882,9113,6342,6991,4928941,0421,0041,057530
       Goodwill 
2,586
2,586
2,586
2,586
2,586
0
2,586
2,586
2,586
2,586
0
0
0
0
0
0
0
0
000000002,5862,5862,5862,58602,5862,5862,5862,5862,586
       Intangible Assets 
0
0
2,092
17,357
25,832
0
72,338
69,209
62,388
55,699
25,902
23,603
20,450
1,982
2,127
1,000
0
0
001,0002,1271,98220,45023,60325,90255,69962,38869,20972,338025,83217,3572,09200
       Other Assets 
0
0
0
0
0
0
0
0
3,661
1,880
2,552
1,560
2,711
3,481
3,804
4,095
0
0
004,0953,8043,4812,7111,5602,5521,8803,66100000000
> Total Liabilities 
2,056
3,562
4,810
7,501
4,747
11,060
11,205
12,382
12,702
8,931
11,777
17,080
9,554
11,724
9,236
19,984
16,576
19,736
19,73616,57619,9849,23611,7249,55417,08011,7778,93112,70212,38211,20511,0604,7477,5014,8103,5622,056
   > Total Current Liabilities 
2,027
3,601
4,810
7,501
4,747
11,060
11,205
12,382
12,702
8,931
11,777
17,080
9,554
10,389
7,693
10,913
12,349
19,607
19,60712,34910,9137,69310,3899,55417,08011,7778,93112,70212,38211,20511,0604,7477,5014,8103,6012,027
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
898
649
3,622
3,948
12,217
12,2173,9483,6226498980000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,401
3,809
12,006
12,0063,8093,401000000000000000
       Accounts payable 
1,785
0
0
6,688
4,034
9,336
9,303
10,352
7,369
4,128
5,941
3,298
5,054
4,725
4,377
4,979
5,040
4,940
4,9405,0404,9794,3774,7255,0543,2985,9414,1287,36910,3529,3039,3364,0346,688001,785
       Other Current Liabilities 
242
3,601
4,810
813
713
1,724
1,902
2,030
5,333
4,803
5,836
13,782
4,500
4,766
2,667
2,312
3,361
1,748
1,7483,3612,3122,6674,7664,50013,7825,8364,8035,3332,0301,9021,7247138134,8103,601242
   > Long-term Liabilities 
29
-39
0
6,688
4,034
9,336
9,303
0
0
0
0
0
5,054
1,335
1,543
9,071
4,227
129
1294,2279,0711,5431,3355,054000009,3039,3364,0346,6880-3929
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,335
0
0
0
0
00001,3350000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
801
1,096
594
0
0
005941,0968010000000000000
> Total Stockholder Equity
35,278
48,435
62,393
93,718
138,190
118,029
227,966
258,772
208,012
169,938
109,816
132,630
104,888
53,160
25,180
-1,078
-4,583
-13,186
-13,186-4,583-1,07825,18053,160104,888132,630109,816169,938208,012258,772227,966118,029138,19093,71862,39348,43535,278
   Common Stock
95,974
110,309
111,338
125,122
138,095
138,351
150,938
151,991
151,991
151,991
151,991
151,991
137,564
100,644
44,913
46,029
65,443
72,993
72,99365,44346,02944,913100,644137,564151,991151,991151,991151,991151,991150,938138,351138,095125,122111,338110,30995,974
   Retained Earnings -92,373-73,404-41,719-12,561-34,747-19,853-163,546-186,334-126,020-88,136-36,792-63,193-93,608-71,971-58,029-43,959-56,054-40,087
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
-20,609
-5,820
-4,986
29,281
75,041
76,631
144,149
157,661
157,661
143,967
144,159
144,185
-12,823
-12,737
-7,172
234
250
250
250250234-7,172-12,737-12,823144,185144,159143,967157,661157,661144,14976,63175,04129,281-4,986-5,820-20,609



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.